©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Sep 15, 2016; 8(9): 682-687
Published online Sep 15, 2016. doi: 10.4251/wjgo.v8.i9.682
Published online Sep 15, 2016. doi: 10.4251/wjgo.v8.i9.682
Pancreatic cancer: New hopes after first line treatment
Francesca Aroldi, Paola Bertocchi, Alberto Zaniboni, Department of Medical Oncology, Poliambulanza Foundation, 25124 Brescia, Italy
Giordano Savelli, Department of Nuclear Medicine, Poliambulanza Foundation, 25124 Brescia, Italy
Edoardo Rosso, Department of General Surgery, Poliambulanza Foundation, 25124 Brescia, Italy
Author contributions: Aroldi F, Bertocchi P, Savelli G and Rosso E contributed equally to this work and wrote the paper; while Zaniboni A made critical revisions related to important intellectual content of the manuscript and approved the final version of the article.
Conflict-of-interest statement: The authors declare that they do not have any conflict of interest.
Correspondence to: Alberto Zaniboni, MD, Department of Medical Oncology, Poliambulanza Foundation, via Bissolati 57, 25124 Brescia, Italy. zanib@numerica.it
Telephone: +39-30-3515553 Fax: +39-30-3518270
Received: March 26, 2016
Peer-review started: March 27, 2016
First decision: May 17, 2016
Revised: June 7, 2016
Accepted: July 14, 2016
Article in press: July 18, 2016
Published online: September 15, 2016
Processing time: 169 Days and 17.8 Hours
Peer-review started: March 27, 2016
First decision: May 17, 2016
Revised: June 7, 2016
Accepted: July 14, 2016
Article in press: July 18, 2016
Published online: September 15, 2016
Processing time: 169 Days and 17.8 Hours
Core Tip
Core tip: Pancreatic cancer is an emerging disease. In this review a possible therapeutic algorithm for second line treatment is hypothesized.